Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|September 29, 2020
Tips for Anxiety in Uncertain Times
Author(s)Jessica A. Gold, MD, MS
Advertisement
In these uncertain times, a lot of patients are likely to exhibit exacerbated symptoms of anxiety and stress. Dr Gold walks us through some tips of how to advise.
Dr Gold is Assistant Professor of Psychiatry,
Twitter:
Advertisement
Related to this article
Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice
2
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
3
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
4
Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship
5